GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] the EU advice in here is 3 years out of date — 26 comments in the full submission. View in context.
357
c/glp1eu·submitted 2 months ago by u/oskar_malinowski

[Discussion] the EU advice in here is 3 years out of date

Discussionbranch of 8 comments

Thinking out loud about this: the EU advice in here is 3 years out of date. 3 years — those are the numbers, and they are the ones I am willing to defend. Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes. Compared prices…

Read the full submission and all 26 comments →

This branch

8 comments, started 2 months ago
u/wanjiru_ramos42 points·2 months ago

a prescription from one member state is not automatically valid in another

replysharereportpermalink
u/plateau_patrol35 points·2 months ago

reimbursement is national, not European, and that is the whole board

replysharereportpermalink
u/honest_syringe_maybe21 points·2 months ago

Is the prescription from the same country as the pharmacy?

replysharereportpermalink
u/patient_labslip_log8 points·2 months ago

reimbursement is national, not European, and that is the whole board

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/solene_ilunga4 points·2 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/oskar_malinowskiOP-27 points·2 months ago

The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.

replysharereportpermalink
u/diego_iyer1 point·2 months ago

Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.

replysharereportpermalink
u/cesar_oyelaran1 point·2 months ago

keep the prescription and the receipt, both matter for claims

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.